To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) (GDC-0449)

This study has been completed.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Rajnesh Prasad, MBA, Children's Hospital & Research Center Oakland
ClinicalTrials.gov Identifier:
NCT00957229
First received: August 5, 2009
Last updated: January 13, 2016
Last verified: January 2016